Heghine Khachatryan: Lupus Anticoagulant – An Old Concept Revisited with New Mechanistic Insight
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, reposted from Nicola Pozzi on LinkedIn:
“Lupus anticoagulant: an old concept revisited with new mechanistic insight
Recent reflections by Nicola Pozzi remind us that some of the most established concepts in hemostasis and thrombosis still warrant critical re-examination.
In collaboration with Vittorio Pengo, this work revisits lupus anticoagulant from both a historical and mechanistic perspective, integrating emerging insights on antiprothrombin antibodies that have accumulated over recent years.
Why this matters
• Lupus anticoagulant remains a cornerstone laboratory criterion in the diagnosis of antiphospholipid syndrome
• Current testing strategies do not always reflect the underlying biological mechanisms
• New mechanistic data challenge how we interpret and even define what we measure in routine coagulation assays
-This raises an important question:
Is it time to reconsider—and potentially rewrite—parts of our coagulation textbooks?
Progress in science is driven by precisely these moments, when well-established paradigms are revisited in light of robust experimental evidence. Understanding what we measure, why we measure it, and what it truly represents biologically is essential for advancing both diagnostics and patient care.
-Lupus anticoagulant and antiprothrombin antibodies: embracing the future
Journal of Thrombosis and Haemostasis”
Quoting Nicola Pozzi‘s post:
“Hematologists and coagulation enthusiasts—this one’s for you!
Lupus anticoagulant: What is it? How do we measure it? Why does it matter for Antiphospholipid Syndrome (APS)?
Vittorio Pengo and I revisit this highly debated topic with a historical perspective, and share novel mechanistic insights we uncovered in recent years that could reshape how we understand and test for lupus anticoagulant.
Could it be time to rewrite the coagulation textbook? Time (and good science) will tell…”
Title: Lupus anticoagulant and antiprothrombin antibodies: embracing the future
Authors: Vittorio Pengo, Nicola Pozzi
Read also: Danny Hsu and Nicola Pozzi on “Tetra-Positive” APS
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC